Figure 1.

Sustained improvement in height SD score (SDS) for heiGHt subjects. Changes in height SDS over 104 weeks in treatment-naïve subjects who enrolled in the heiGHt trial and continued into the enliGHten trial. Subjects who were treated with daily somatropin in heiGHt (blue bars) switched to weekly lonapegsomatropin in enliGHten (orange bars). Subjects who were on weekly lonapegsomatropin in heiGHt continued weekly lonapegsomatropin in enliGHten (green bars). *Based on n = 159 at heiGHt trial baseline. ⁺ΔHeight SDS value is the least squares means from the analysis of covariance model.